ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Quotes, Forecast and News Summary

Q: What sector and industry does ORIC Pharmaceuticals (ORIC) operate in?

ORIC Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ORIC Pharmaceuticals Stock (NASDAQ: ORIC) stock price, news, charts, stock research, profile.

Open	$8.72
Close	$9.12
Volume / Avg.	317.03K / 447.46K
Day Range	$8.52 - $9.30
52 Wk Range	6.33 - 16.65
Market Cap	$643.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	16.76%
Days to Cover	25.29

Recent News

ORIC: Working with Two Pharma Giants, Analysts See +100% Upside

ORIC Pharmaceuticals (NASDAQ:ORIC) is a small-cap pharma stock. It aims to make a difference with its potentially "best-in-class" treatments. The company’s shares have not had a great year, returning -4% in 2024.

MarketBeat

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.

Chris Katje

Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.72
Close	$9.12
Volume / Avg.	317.03K / 447.46K
Day Range	$8.52 - $9.30
52 Wk Range	6.33 - 16.65
Market Cap	$643.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	16.76%
Days to Cover	25.29

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ORIC Pharmaceuticals (ORIC) stock?

You can purchase shares of ORIC Pharmaceuticals (NASDAQ:ORIC) through any online brokerage.

View our list of the best stock brokerages

Who are ORIC Pharmaceuticals (ORIC) competitors?

Other companies in ORIC Pharmaceuticals’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), Altimmune (NASDAQ:ALT) and Replimune Group (NASDAQ:REPL).

What is the forecast, or price target, for ORIC Pharmaceuticals (ORIC) stock?

ORIC Pharmaceuticals has a consensus price target of $19.27.

What is the current price for ORIC Pharmaceuticals (ORIC)?

The stock price for ORIC Pharmaceuticals (NASDAQ: ORIC) is $9.12 last updated November 21, 2024 at 4:00 PM EST.

Does ORIC Pharmaceuticals (ORIC) pay a dividend?

There are no upcoming dividends for ORIC Pharmaceuticals.

When is ORIC Pharmaceuticals (NASDAQ:ORIC) reporting earnings?

ORIC Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is ORIC Pharmaceuticals (ORIC) going to split?

There is no upcoming split for ORIC Pharmaceuticals.

What sector and industry does ORIC Pharmaceuticals (ORIC) operate in?

ORIC Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

ORIC Pharmaceuticals

ORIC Pharmaceuticals (ORIC) Forecast